Linparza
(Olaparib)
(50 mg)
(448)
(Capsules)
Lynparza (olaparib) 50 mg 448 Astra Zeneca, United Kingdom.
Article:
In Stock
testimony
Lynparza is indicated as monotherapy for the maintenance treatment of adult patients with platinum-responsive recurrent serous epithelial ovarian, fallopian tube, or high-grade BRCA -mutated primary peritoneal cancer (germinal and/or somatic) who have achieved complete or partial responses. for platinum-based chemotherapy.
-
Commercial name:Linparza
-
Сhemical name:Olaparib
-
Dosage:50 mg
-
Quantity:448
-
Release form:Capsules
-
Производитель:Астра Зенека
No reviews yet